EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Proteomics of post mortem brains in early‐ and late‐onset Alzheimer's disease: Unraveling differential Aβ effects and potential AD biomarkers

Evangelia Thanou iD, Andrea Ganz, Débora Pita-Illobre, Frank Koopmans, Jeroen J M Hoozemans, Annemieke Rozemuller, Henne Holstege, August B Smit, Ka Wan Li

Alzheimer's & Dementia · 2026

DOI: 10.1002/alz.71662 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2026. Verfasst von Evangelia Thanou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Cellular Neurobiology, Center for Neurogenomics & Cognitive Research, Neuroscience, Vrije Universiteit Amsterdam, Amsterd…. Hauptthemen laut MEDLINE: Alzheimer Disease, Proteomics, Amyloid beta-Peptides, Brain. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EU Marie Curie ITN EuroNeurotrophin, Dutch Research Council (NWO), OPD-ZonMW via the MODEM consortium.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Alzheimer's disease (AD) occurs primarily as late‑onset (LOAD) and less frequently as early‑onset (EOAD). Its defining pathologies are hyperphosphorylated tau tangles and amyloid beta (Aβ) plaques. METHODS We analyzed the proteomes of 115 post mortem temporal lobe samples by mass spectrometry and searched with a dedicated AD spectral library including tau post‑translational modifications and Aβ isoforms to examine global protein changes in LOAD and EOAD. RESULTS AD tissues showed mitochondrial and synaptic pathway downregulation and immune and small‑molecule metabolic process upregulation, with EOAD exhibiting larger fold changes. AD biomarkers were elevated, and two multi‑phosphorylated tau peptides (p‑tau231/p‐tau235 and p‐tau231/p‐tau235/p‐tau237) were detected predominantly in AD. Aβ was present in 45% of cognitively unimpaired elderly controls, with subtle proteome changes resembling an early stage of neurodegeneration. DISCUSSION EOAD appears more aggressive. Tau p‐tau231/p‐tau235 and p‐tau231/p‐tau235/p‐tau237 hold promise as novel AD biomarkers. Aβ’s detection in cognitively unimpaired elderly controls precedes clinical AD symptoms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseProteomicsAmyloid beta-PeptidesBrainHumansBiomarkersFemaletau ProteinsMaleAgedAged, 80 and overAge of OnsetProteomeAutopsyPhosphorylation

Stichwörter der Autor:innen

Aβbiomarkersearly‐onset Alzheimer's diseaseglobal protein changeslate‐onset Alzheimer's diseasephosphorylated tauproteomics

Substanzen

BiomarkersAmyloid beta-Peptidestau ProteinsProteome

Autor:innen und Institutionen

  • Department of Molecular and Cellular Neurobiology, Center for Neurogenomics & Cognitive Research, Neuroscience, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Department of Pathology, Amsterdam Neuroscience, Amsterdam UMC, Amsterdam, The Netherlands.
  • Department of Clinical Genetics, Amsterdam Neuroscience, Amsterdam UMC, Amsterdam, The Netherlands.

ORCID-Profile: Evangelia Thanou

Förderung

  • EU Marie Curie ITN EuroNeurotrophin
  • Dutch Research Council (NWO)
  • OPD-ZonMW via the MODEM consortium

Zitieren

APA

Thanou, E., Ganz, A., Pita-Illobre, D., Koopmans, F., Hoozemans, J. J. M., Rozemuller, A., Holstege, H., Smit, A. B., & Li, K. W. (2026). Proteomics of post mortem brains in early‐ and late‐onset Alzheimer's disease: Unraveling differential Aβ effects and potential AD biomarkers. Alzheimer's & Dementia. https://doi.org/10.1002/alz.71662

Vancouver

Thanou E, Ganz A, Pita-Illobre D, Koopmans F, Hoozemans JJM, Rozemuller A, et al. Proteomics of post mortem brains in early‐ and late‐onset Alzheimer's disease: Unraveling differential Aβ effects and potential AD biomarkers. Alzheimer's & Dementia. 2026. doi:10.1002/alz.71662

BibTeX
@article{Thanou2026,
  author = {Thanou, Evangelia and Ganz, Andrea and Pita-Illobre, Débora and Koopmans, Frank and Hoozemans, Jeroen J M and Rozemuller, Annemieke and Holstege, Henne and Smit, August B and Li, Ka Wan},
  title = {Proteomics of post mortem brains in early‐ and late‐onset Alzheimer's disease: Unraveling differential Aβ effects and potential AD biomarkers},
  journal = {Alzheimer's & Dementia},
  year = {2026},
  doi = {10.1002/alz.71662}
}
Kostenlos starten →